張皓智醫師詳細介紹

國立陽明大學醫學士

2025-迄今臺北榮民總醫院內科部心臟內科主治醫師

-迄今國立陽明交通大學醫學院內科學科講師

2022-2024臺北榮民總醫院桃園分院心臟內科主治醫師

2020-2022臺北榮民總醫院蘇澳暨員山分院心臟內科主治醫師

2017-2020臺北榮民總醫院心臟內科住院總醫師

2014-2017臺北榮民總醫院內科部住院醫師

成人心臟內科

心臟超音波

心肌病變

肺動脈高壓

心臟衰竭

中華民國介入性心臟血管專科醫師

中華民國重症醫學專科醫師

中華民國內科專科醫師

中華民國心臟血管內科專科醫師

Chang HC, Kuo L, Sung SH, Niu DM, Yu WC. Prognostic Implications of Left Ventricular Hypertrophy and Mechanical Function in Fabry Disease: A Longitudinal Cohort Study. J Am Soc Echocardiogr. 2024;37(8):787-796.

Chang HC, Tseng CH, Huang WM, Lee CW, Yu WC, Cheng HM, Chiang CE, Chen CH, Sung SH. Supranormal Left Ventricular Ejection Fraction, Concentric Remodeling, and Long-Term Survival. JACC: Asia. 2024;4(12):928–937.

Chang HC, Chen YY, Kuo TT, Lin YJ, Chien KL, Chang HY, Hung CL, Chung FP. Sodium Glucose Transporter 2 Inhibitors Versus Metformin on Cardiovascular and Renal Outcomes in Patients With Diabetes With Low Cardiovascular Risk: A Nationwide Cohort Study. J Am Heart Assoc. 2024;13(8):e032397.

Chang HC, Kuo L, Sung SH, Weng CY, Chen CK, Niu DM, Chen SA, Yu WC. Left Ventricular Apical Aneurysm in Fabry Disease: Implications for Clinical Significance and Risk Stratification. J Am Heart Assoc. 2023;12(1):e027041.

Chang HC, Kuo TT, Chen YY, Lin YJ, Chang HY, Hung CL, Chung FP. Sodium-Glucose Cotransporter 2 Inhibitors in Cardiovascular and Renal Outcomes in Patients With Diabetes but Without Established Cardiovascular Disease: A Nationwide Population-Based Cohort Study. Diabetes Care. 2022;45(9):129-130.